Neuropace Stock Price History
| NPCE Stock | USD 9.36 0.30 3.31% |
Below is the normalized historical share price chart for Neuropace extending back to April 22, 2021. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Neuropace stands at 9.36, as last reported on the 22nd of July, with the highest price reaching 9.40 and the lowest price hitting 9.00 during the day.
If you're considering investing in Neuropace Stock, it is important to understand the factors that can impact its price. Neuropace has Sharpe Ratio of -0.0165, which conveys that the firm had a -0.0165 % return per unit of risk over the last 3 months. Neuropace exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Neuropace's Risk Adjusted Performance of 0.0082, mean deviation of 3.11, and Standard Deviation of 5.33 to check out the risk estimate we provide.
At present, Neuropace's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. . At present, Neuropace's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 42.71, whereas Price Earnings Ratio is forecasted to decline to (12.61). Neuropace Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 22nd of April 2021 | 200 Day MA 11.0872 | 50 Day MA 12.3142 | Beta 2.042 |
Neuropace | Build AI portfolio with Neuropace Stock |
Sharpe Ratio = -0.0165
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NPCE |
Estimated Market Risk
| 5.5 actual daily | 49 51% of assets are more volatile |
Expected Return
| -0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Neuropace is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neuropace by adding Neuropace to a well-diversified portfolio.
Price Book 12.6496 | Enterprise Value Ebitda (16.94) | Price Sales 3.6414 | Shares Float 21.3 M | Wall Street Target Price 17.125 |
Neuropace Stock Price History Chart
There are several ways to analyze Neuropace Stock price data. The simplest method is using a basic Neuropace candlestick price chart, which shows Neuropace price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | May 21, 2025 | 18.13 |
| Lowest Price | July 18, 2025 | 9.06 |
Neuropace July 22, 2025 Stock Price Synopsis
Various analyses of Neuropace's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Neuropace Stock. It can be used to describe the percentage change in the price of Neuropace from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Neuropace Stock.| Neuropace Price Rate Of Daily Change | 1.03 | |
| Neuropace Accumulation Distribution | 11,190 | |
| Neuropace Price Action Indicator | 0.31 | |
| Neuropace Price Daily Balance Of Power | 0.75 |
Neuropace July 22, 2025 Stock Price Analysis
Neuropace Stock Price History Data
The price series of Neuropace for the period between Wed, Apr 23, 2025 and Tue, Jul 22, 2025 has a statistical range of 9.07 with a coefficient of variation of 19.39. The daily prices for the period are spread out with arithmetic mean of 12.03. The median price for the last 90 days is 11.25.| Open | High | Low | Close | Volume | ||
07/21/2025 | 9.15 | 9.40 | 9.00 | 9.36 | 262,962 | |
07/18/2025 | 9.21 | 9.36 | 9.01 | 9.06 | 132,243 | |
| 07/17/2025 | 9.08 | 9.40 | 9.04 | 9.08 | 191,406 | |
07/16/2025 | 9.42 | 9.43 | 8.97 | 9.11 | 260,321 | |
07/15/2025 | 9.58 | 9.58 | 9.26 | 9.35 | 191,786 | |
07/14/2025 | 9.50 | 9.64 | 9.24 | 9.55 | 198,855 | |
| 07/11/2025 | 10.18 | 10.27 | 9.50 | 9.52 | 232,551 | |
07/10/2025 | 10.09 | 10.39 | 9.95 | 10.17 | 301,788 | |
07/09/2025 | 10.38 | 10.58 | 9.91 | 10.08 | 274,442 | |
07/08/2025 | 10.22 | 10.38 | 10.10 | 10.36 | 138,603 | |
07/07/2025 | 10.32 | 10.60 | 10.05 | 10.22 | 223,421 | |
07/03/2025 | 10.44 | 10.64 | 10.24 | 10.39 | 84,321 | |
07/02/2025 | 10.47 | 10.60 | 10.20 | 10.42 | 236,560 | |
| 07/01/2025 | 11.10 | 11.37 | 10.10 | 10.48 | 415,258 | |
06/30/2025 | 10.81 | 11.53 | 10.73 | 11.14 | 618,100 | |
| 06/27/2025 | 11.00 | 11.04 | 10.32 | 10.71 | 2,293,234 | |
06/26/2025 | 10.60 | 11.03 | 10.27 | 10.94 | 222,147 | |
| 06/25/2025 | 10.14 | 10.59 | 9.88 | 10.57 | 405,321 | |
| 06/24/2025 | 10.50 | 10.90 | 10.20 | 10.76 | 324,074 | |
06/23/2025 | 10.37 | 10.61 | 9.85 | 10.57 | 503,959 | |
| 06/20/2025 | 10.60 | 10.73 | 10.38 | 10.41 | 273,094 | |
06/18/2025 | 10.75 | 10.92 | 10.45 | 10.60 | 237,824 | |
| 06/17/2025 | 11.09 | 11.19 | 10.72 | 10.78 | 284,398 | |
06/16/2025 | 11.20 | 11.59 | 10.98 | 11.09 | 201,373 | |
06/13/2025 | 11.11 | 11.78 | 11.00 | 11.07 | 503,419 | |
06/12/2025 | 11.80 | 12.03 | 11.11 | 11.23 | 331,191 | |
06/11/2025 | 12.98 | 13.19 | 11.80 | 11.83 | 351,257 | |
06/10/2025 | 13.05 | 13.19 | 12.81 | 12.94 | 231,759 | |
06/09/2025 | 13.37 | 13.37 | 12.63 | 12.93 | 204,743 | |
06/06/2025 | 13.35 | 13.84 | 12.87 | 13.15 | 212,281 | |
06/05/2025 | 13.55 | 13.91 | 12.89 | 13.28 | 290,701 | |
06/04/2025 | 13.55 | 13.77 | 13.10 | 13.17 | 288,500 | |
| 06/03/2025 | 13.11 | 13.61 | 12.48 | 13.54 | 262,272 | |
06/02/2025 | 13.07 | 13.22 | 12.43 | 13.04 | 379,388 | |
05/30/2025 | 13.11 | 13.25 | 12.51 | 13.22 | 285,294 | |
05/29/2025 | 12.47 | 13.17 | 12.01 | 13.11 | 571,336 | |
| 05/28/2025 | 13.17 | 13.59 | 11.40 | 12.46 | 761,307 | |
05/27/2025 | 13.37 | 14.75 | 10.61 | 12.66 | 1,910,795 | |
05/23/2025 | 17.72 | 18.25 | 16.95 | 17.68 | 225,223 | |
05/22/2025 | 17.94 | 18.37 | 17.38 | 17.87 | 331,529 | |
05/21/2025 | 17.78 | 18.98 | 17.45 | 18.13 | 545,408 | |
| 05/20/2025 | 17.00 | 18.25 | 16.50 | 17.99 | 605,151 | |
05/19/2025 | 17.10 | 17.75 | 16.91 | 17.00 | 537,675 | |
05/16/2025 | 16.86 | 17.85 | 16.42 | 17.49 | 871,483 | |
| 05/15/2025 | 15.83 | 17.73 | 15.26 | 17.08 | 863,782 | |
05/14/2025 | 14.30 | 16.36 | 13.31 | 15.60 | 811,137 | |
05/13/2025 | 13.60 | 13.61 | 12.91 | 12.95 | 211,998 | |
05/12/2025 | 13.33 | 13.50 | 12.86 | 13.37 | 147,878 | |
05/09/2025 | 12.60 | 13.19 | 12.52 | 12.89 | 188,035 | |
05/08/2025 | 12.31 | 12.91 | 11.88 | 12.55 | 155,293 | |
05/07/2025 | 11.82 | 12.24 | 11.56 | 12.12 | 103,005 | |
05/06/2025 | 11.34 | 11.90 | 11.19 | 11.69 | 107,670 | |
05/05/2025 | 11.79 | 12.04 | 11.50 | 11.53 | 154,435 | |
05/02/2025 | 11.94 | 12.49 | 11.58 | 11.98 | 245,722 | |
05/01/2025 | 11.69 | 11.96 | 11.46 | 11.79 | 101,082 | |
04/30/2025 | 11.73 | 11.86 | 11.26 | 11.69 | 108,610 | |
04/29/2025 | 11.61 | 12.35 | 11.44 | 11.98 | 169,385 | |
04/28/2025 | 11.17 | 11.72 | 11.02 | 11.62 | 157,411 | |
04/25/2025 | 11.10 | 11.29 | 10.89 | 11.15 | 97,294 | |
04/24/2025 | 10.92 | 11.36 | 10.92 | 11.25 | 101,820 | |
| 04/23/2025 | 11.35 | 11.76 | 10.75 | 10.91 | 123,357 |
About Neuropace Stock history
Neuropace investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neuropace is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neuropace will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neuropace stock prices may prove useful in developing a viable investing in Neuropace
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 29.1 M | 23.1 M | |
| Net Loss | -42.4 M | -44.5 M |
Neuropace Quarterly Net Working Capital |
|
Neuropace Stock Technical Analysis
Neuropace technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Neuropace Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Neuropace's price direction in advance. Along with the technical and fundamental analysis of Neuropace Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neuropace to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0082 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.79) | |||
| Treynor Ratio | 0.2948 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Neuropace Stock analysis
When running Neuropace's price analysis, check to measure Neuropace's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuropace is operating at the current time. Most of Neuropace's value examination focuses on studying past and present price action to predict the probability of Neuropace's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuropace's price. Additionally, you may evaluate how the addition of Neuropace to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |